| View |
|
DRP-841-05
|
Losartan Potassium
|
Bepsar
|
50 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals and Pharmaceuticals Limited)
|
India
|
-
|
21 April 2022
|
04 May 2027
|
| View |
|
DRP-4087-07
|
Amoxicillin (as trihydrate)
|
None
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Brawn Laboratories Limited
|
India
|
-
|
20 April 2022
|
06 November 2027
|
| View |
|
DRP-7469-01
|
Methylprednisolone (as sodium succinate)
|
Mepresone 40
|
40 mg
|
Powder for Injection (I.V./I.M.)
|
Corticosteroid
|
Biorx Pharma Labs LLP
|
India
|
-
|
19 April 2022
|
20 November 2027
|
| View |
|
DRP-3859-02
|
Cefixime (as trihydrate)
|
Cefxitrix
|
400 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
XL Laboratories Pvt. Ltd.
|
India
|
-
|
08 April 2022
|
24 July 2027
|
| View |
|
DR-864-02
|
Polymyxin B Sulfate + Neomycin Sulfate + Dexamethasone (as Sodium Phosphate)
|
Neotic
|
10,000 units/5 mg/1 mg per mL
|
Otic Solution
|
Antibacterial / Corticosteroid
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
05 April 2022
|
31 January 2028
|
| View |
|
DRP-6481-01
|
Tamsulosin Hydrochloride
|
Tamson
|
400 mcg
|
Prolonged Release Tablet
|
Alpha-Adrenoreceptor Antagonist
|
Steril-Gene Life Sciences (P) LTD.
|
India
|
-
|
31 May 2022
|
25 January 2026
|
| View |
|
DRP-8465-01
|
Amoxicillin (as Trihydrate)
|
Musital
|
250 mg/5 mL
|
Powder for Suspension
|
ANTIBACTERIAL
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2022
|
27 September 2027
|
| View |
|
DRP-10694-01
|
Etoricoxib
|
Evacoxib
|
90 mg
|
Film-Coated Tablet
|
Non-steroid Anti-inflammatory and Anti-rheumatic Drug (NSAID) / Selective COX-2 Inhibitor
|
Acme Formulation Pvt. Ltd.
|
India
|
-
|
31 May 2022
|
10 November 2026
|
| View |
|
DRP-11059-02
|
Ketoanalogues + Essential Amino Acids
|
Ketocass
|
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Celogen Generic Private Ltd.
|
India
|
-
|
31 May 2022
|
21 January 2027
|
| View |
|
DRP-5460-04
|
Metronidazole
|
Metrocare
|
5 mg/mL (500 mg/100 mL)
|
Solution for I.V. Infusion
|
-
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd
|
China
|
Renewal
|
29 May 2023
|
31 July 2028
|
| View |
|
DRP-8832-03
|
Ceftriaxone (as Sodium)
|
Ceftnest
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
-
|
30 May 2022
|
10 November 2025
|
| View |
|
DRP-10868-02
|
Ascorbic Acid + Zinc
|
Meedzinc
|
533.40 mg (equivalent to 600 mg Sodium Ascorbate) + 10mg (equivalent to 27.45 mg Zinc Sulfate)
|
Capsule
|
Vitamin/Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
-
|
30 May 2022
|
30 October 2025
|
| View |
|
DRP-5357-06
|
Co-Amoxiclav
|
Unbranded
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
01 February 2024
|
20 June 2029
|
| View |
|
DRP-10763-03
|
Dutasteride + Tamsulosin hydrochloride
|
Urogen
|
500 mcg/400 mcg
|
Capsule
|
Alpha-adrenoreceptor Antagonists
|
Globela Pharma Private Limited
|
India
|
-
|
27 May 2022
|
16 November 2026
|
| View |
|
DRP-11108-01
|
Butamirate Citrate
|
Diabutrate
|
50 mg
|
Film-Coated Sustained-Release Tablet
|
Antitussive
|
Orion Pharma Ltd.
|
Bangladesh
|
-
|
27 May 2022
|
03 February 2027
|
| View |
|
DRP-11998
|
Aminophylline
|
Aminosol
|
25 mg/mL (250 mg/10 mL)
|
Solution for Injection (I.V.)
|
-
|
Grand Pharmaceutical (China) Co., Ltd
|
China
|
-
|
27 May 2022
|
13 May 2027
|
| View |
|
DRP-2315-01
|
Iron (as fumarate) + Folic acid + Cyanocobalamin (Vitamin B12)
|
Hemoramin
|
165 mg / 800 mcg / 3 mcg
|
Capsule
|
Anti-anemic
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
-
|
26 May 2022
|
28 April 2027
|
| View |
|
DRP-6717-17
|
Omeprazole (as sodium)
|
Omezar
|
40mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
Alwin DMD Pharmaceuticals
|
India
|
-
|
26 May 2022
|
02 June 2026
|
| View |
|
DRP-6928-04
|
Pregabalin
|
Neurokem
|
150 mg
|
Capsule
|
Anticonvulsant
|
Rhydburg Pharmaceuticals Limited
|
India
|
-
|
26 May 2022
|
21 November 2026
|
| View |
|
DRP-11976
|
Salbutamol (as sulfate)
|
Salbulife
|
1mg/mL (2.5mg/2.5mL)
|
Solution for Inhalation
|
Selective beta-2-adrenoreceptor agonist
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Renewal
|
24 January 2024
|
27 December 2028
|